UnknownNot applicableNCT01354587

Evaluation of Efficacy and Tolerability of Hizentra®

Studying Primary immunodeficiency

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
University of South Florida
Principal Investigator
John Sleasman, MD
University of South Florida
Intervention
Hizentra(drug)
Enrollment
50 enrolled
Eligibility
1-75 years · All sexes
Timeline
20102012

Study locations (1)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT01354587 on ClinicalTrials.gov

Other trials for Primary immunodeficiency

Additional recruiting or active studies for the same condition.

See all trials for Primary immunodeficiency

← Back to all trials